Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.

A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...

A higher dose and shorter treatment time of a cornerstone tuberculosis (TB) drug has proven to be safe for patients, according to a clinical trial led by researchers at St George's, University of ...

The price of pretomanid, a key component used in the treatment of drug-resistant tuberculosis (TB), dropped by 25% in April, to less than $1 per day, primarily owing to Indian manufacturers joining in ...

Researcher found that exposed individuals with confirmed TB infection -- i.e. a positive skin or blood test -- should receive priority treatment in settings with a low prevalence of the disease, ...

Patient choice in taking treatment is framed by the physiological and psychological impacts of the disease and also by the social and cultural structures in which the person is immersed. [68] Patient ...

Here's what tuberculosis is, how it's transmitted and how you can expect to have it treated if it affects you or someone you ...

"In our study of US-bound immigrants in Vietnam during their required overseas medical examination prior to migration to the United States, we identified a high proportion of US-bound immigrants with ...

Blood infection, medically known as sepsis, is one of the leading causes of death, because the body’s response to infection damages tissue and causes organs to fail. Africa has the ...